166 related articles for article (PubMed ID: 36532767)
1. Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling.
Xu J; Sun S; Zhang W; Dong J; Huang C; Wang X; Jia M; Yang H; Wang Y; Jiang Y; Cao L; Huang Z
Front Pharmacol; 2022; 13():1027577. PubMed ID: 36532767
[TBL] [Abstract][Full Text] [Related]
2. Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway.
Wang M; Xing S; Jia J; Zeng W; Lei J; Qian Y; Xiong Z; Wang X; Cao L; Wang Y; Wang Y; Jiang Y; Huang Z
Biomed Pharmacother; 2023 May; 161():114462. PubMed ID: 36933380
[TBL] [Abstract][Full Text] [Related]
3. 2,2'-((1R,3R,4S)-4-methyl-4-vinylcyclohexane-1,3-diyl) bis(prop-2-en-1-amine), a bisamino derivative of β-Elemene, inhibits glioblastoma growth through downregulation of YAP signaling.
Cao LY; Xu JY; Zhuo XT; Zhang W; Wei LJ; Dong JH; Bai RR; Wang X; Jiang YY; Wang YJ; Ye XY; Xie T; Huang ZH
Am J Cancer Res; 2022; 12(12):5484-5499. PubMed ID: 36628286
[TBL] [Abstract][Full Text] [Related]
4. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
[TBL] [Abstract][Full Text] [Related]
5. Fraxinellone inhibits progression of glioblastoma via regulating the SIRT3 signaling pathway.
Shi J; Sun S; Xing S; Huang C; Huang Y; Wang Q; Xue X; Chen Z; Wang Y; Huang Z
Biomed Pharmacother; 2022 Sep; 153():113416. PubMed ID: 36076484
[TBL] [Abstract][Full Text] [Related]
6. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
[TBL] [Abstract][Full Text] [Related]
7. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
[TBL] [Abstract][Full Text] [Related]
8. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
10. Atractylon inhibits the tumorigenesis of glioblastoma through SIRT3 signaling.
Sun S; Shi J; Wang X; Huang C; Huang Y; Xu J; Jiang Y; Cao L; Xie T; Wang Y; Huang Z
Am J Cancer Res; 2022; 12(5):2310-2322. PubMed ID: 35693089
[TBL] [Abstract][Full Text] [Related]
11. Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
Saunders JT; Holmes B; Benavides-Serrato A; Kumar S; Nishimura RN; Gera J
J Neurooncol; 2021 Apr; 152(2):217-231. PubMed ID: 33511508
[TBL] [Abstract][Full Text] [Related]
12. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
13. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
Wang Y; Wang K; Fu J; Zhang Y; Mao Y; Wang X; Wang X; Yu R; Zhou X
Neuro Oncol; 2022 Dec; 24(12):2107-2120. PubMed ID: 35723276
[TBL] [Abstract][Full Text] [Related]
14. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
[TBL] [Abstract][Full Text] [Related]
15. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract][Full Text] [Related]
16. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.
Barrette AM; Ronk H; Joshi T; Mussa Z; Mehrotra M; Bouras A; Nudelman G; Jesu Raj JG; Bozec D; Lam W; Houldsworth J; Yong R; Zaslavsky E; Hadjipanayis CG; Birtwistle MR; Tsankova NM
Neuro Oncol; 2022 May; 24(5):694-707. PubMed ID: 34657158
[TBL] [Abstract][Full Text] [Related]
17. AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway.
Gao L; Liu J; Xu P; Deng G; Liu B; Yuan F; Tan Y; Sun Q; Xu Y; Zhang H; Qi Y; Han S; Yang K; Geng R; Jiang H; Chen Q
Front Pharmacol; 2020; 11():1102. PubMed ID: 32848734
[TBL] [Abstract][Full Text] [Related]
18. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling.
Li C; Yang J; Wang W; Li R
J Bioenerg Biomembr; 2021 Feb; 53(1):61-71. PubMed ID: 33394310
[TBL] [Abstract][Full Text] [Related]
19. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
[TBL] [Abstract][Full Text] [Related]
20. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
